Chronic effect of antidopaminergic drugs or estrogen on male wistar rat lactotrophs and somatotrophs.
The aim of the present study was to evaluate the effect of antidopaminergic agents on the somatotrophs in the presence of hyperprolactinemia. Adult male Wistar rats were divided into 6 groups: a control group and five groups chronically treated (60 days) with haloperidol, fluphenazine, sulpiride, metoclopramide or estrogen. Somatotrophs and lactotrophs were identified by immunohistochemistry and the data are reported as percent of total anterior pituitary cells counted. The drugs significantly increased the percentage of lactotrophs: control (mean +/- SD) 21.3 +/- 4.4, haloperidol 27.8 +/- 2.2, fluphenazine 34.5 +/- 3.6, sulpiride 32.7 +/- 3.5, metoclopramide 33.4 +/- 5.5 and estrogen 42.4 +/- 2.8. A significant reduction in somatotrophs was observed in animals treated with haloperidol (23.1 +/- 3.0), fluphenazine (22.1 +/- 1.1) and metoclopramide (24.2 +/- 3.0) compared to control (27.3 +/- 3.8), whereas no difference was observed in the groups treated with sulpiride (25.0 +/- 2.2) and estrogen (27.1 +/- 2.8). In the groups in which a reduction occurred, this may have simply been due to dilution, secondary to lactotroph hyperplasia. In view of the duplication of the percentage of prolactin-secreting cells, when estrogen was applied, the absence of a reduction in the percent of somatotrophs suggests a replication effect on this cell population. These data provide additional information about the direct or indirect effect of drugs which, in addition to interfering with the dopaminergic system, may act on other pituitary cells as well as on the lactotrophs.
Oliveira
M C
MC
Endocrinologia, Fundação Faculdade Federal de Ciências Médicas de Porto Alegre, Porto Alegre, RS, Brasil. mco@portoweb.com.br
Messinger
H P
HP
Tannhauser
M
M
Barbosa-Coutinho
L
L
D000818:Animals; D018492:Dopamine Antagonists / Q000494:pharmacology*; D004967:Estrogens / Q000494:pharmacology*; D005476:Fluphenazine / Q000494:pharmacology; D013006:Growth Hormone / Q000032:analysis / Q000187:drug effects*; D006220:Haloperidol / Q000494:pharmacology; D006966:Hyperprolactinemia / Q000378:metabolism*; D008297:Male; D010902:Pituitary Gland / Q000166:cytology / Q000187:drug effects*; D011388:Prolactin / Q000032:analysis / Q000187:drug effects*; D051381:Rats; D017208:Rats, Wistar; D013469:Sulpiride / Q000494:pharmacology
D018492:Dopamine Antagonists; D004967:Estrogens; D013469:Sulpiride; D011388:Prolactin; D013006:Growth Hormone; D006220:Haloperidol; D005476:Fluphenazine